Trial
NCT05252520
A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese Participants
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Healthy
Intervention
JNJ-77474462
Why stopped
The development of bermekimab in Immunology is stopped
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-03